Quarterly ResultMay 6, 2026, 04:47 PM
Edgewell Reports Q1 Net Loss $(10.6)M; Completes Feminine Care Divestment
AI Summary
Edgewell Personal Care Company reported a net loss of $(10.6) million, or $(0.23) per share, for the three months ended March 31, 2026, a significant decline from net income of $29.0 million in the prior year. This period included the completion of the Feminine Care segment divestiture to Essity for approximately $340.0 million, which resulted in a $(14.6) million loss from discontinued operations and a $37.4 million goodwill impairment charge. The company also continued its restructuring initiatives, incurring $14.0 million in charges for the quarter.
Key Highlights
- Net loss for Q1 2026 was $(10.6) million, compared to net income of $29.0 million in Q1 2025.
- Basic loss per share for Q1 2026 was $(0.23), down from earnings of $0.60 in Q1 2025.
- Net sales from continuing operations slightly increased to $519.5 million in Q1 2026 from $516.6 million in Q1 2025.
- Feminine Care segment divestiture closed on February 2, 2026, generating approximately $340.0 million in proceeds.
- A goodwill impairment loss of $37.4 million was recorded in Q1 2026 related to the Feminine Care segment.
- Total restructuring charges for continuing operations were $14.0 million for Q1 2026 and $32.1 million for the six months ended March 31, 2026.
- Cash and cash equivalents increased to $299.7 million as of March 31, 2026, from $225.7 million at September 30, 2025.
- Long-term debt decreased to $1,244.4 million as of March 31, 2026, from $1,383.3 million at September 30, 2025.